S100A6 and neoplasm: In this study, we initiated an exploration into the heterogeneity landscape of malignant cells in HCC, revealing a tripartite classification comprising Metab-subtype (ARG1+ tumor cell), Prol-phenotype (TOP2A+ tumor cell), and EMT-subtype (S100A6+ tumor cell).